Ultragenyx Pharmaceutical (RARE) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the Chairman, with all board members and key executives present.

• Notice of meeting and proxy statement distributed to all eligible stockholders.

• Quorum established with approximately 86% of shares represented.

Board and executive committee updates

• Board members and executive leadership, including the CEO and Chief Legal Officer, introduced at the start.

Shareholder proposals

• Four proposals presented: reelection of three directors, approval of amended incentive plan, ratification of auditor, and advisory vote on executive compensation.

• Board recommended voting in favor of all proposals.